09.07 09:02 | dpa-AFX: *BECKMAN COULTER UNVEILS INTEGRATED CHEMISTRY AND IMMUNOASSAY ANALYZER |
19.06 13:40 | dpa-AFX: *DANAHER APPOINTS JULIE SAWYER MONTGOMERY TO EVP FOR DIAGNOSTICS, EFFECTIVE AS OF JULY 1, 2024 |
05.06 13:01 | dpa-AFX: *DANAHER APPOINTS MARTIN STUMPE TO NEW ROLE OF CHIEF DATA & ARTIFICIAL INTELLIGENCE OFFICER |
09.05 13:19 | dpa-AFX: *DANAHER LAUNCHES COLLABORATION WITH JOHNS HOPKINS UNIVERSITY TO IMPROVE NEUROLOGICAL DIAGNOSIS |
07.05 22:18 | dpa-AFX: *DANAHER CORP. (DHR) DECLARES QUARTERLY DIVIDEND OF $ 0.27, RECORD DATE 6/28/2024 |
23.04 17:14 | dpa-AFX: Danaher Stock Climbs After Q1 Earnings Beats Estimates |
23.04 15:33 | dpa-AFX: *DANAHER +6,4% - KURS NÄHERT SICH DEM MÄRZ-HOCH |
23.04 13:07 | dpa-AFX: AKTIEN IM FOKUS: US-Konkurrent Danaher schiebt Merck KGaA und Sartorius an |
23.04 13:07 | AKTIEN IM FOKUS: US-Konkurrent Danaher schiebt Merck KGaA und Sartorius an |
23.04 13:03 | dpa-AFX: Danaher Q1 24 Earnings Conference Call At 8:00 AM ET |
23.04 13:01 | dpa-AFX: AKTIEN-FLASH: US-Konkurrent Danaher schiebt Merck KGaA und Sartorius an |
23.04 12:53 | dpa-AFX: *DANAHER VORBÖRSLICH NUN +8,3% |
23.04 12:50 | dpa-AFX: *DANAHER VORBÖRSLICH +5,1% - ZAHLEN BESSER ALS ERWARTET |
23.04 12:26 | dpa-AFX: Danaher Issues Q2, FY24 Guidance |
23.04 12:09 | dpa-AFX: *DANAHER Q1 ADJ. EPS FROM CONT. OPS. $1.92 VS. $2.05 LAST YEAR |
23.04 12:09 | dpa-AFX: *DANAHER Q1 SALES $5.796 BLN VS. $5.949 BLN LAST YEAR |
23.04 12:08 | dpa-AFX: *DANAHER Q1 OPERATING PROFIT $1.312 BLN VS. $1.517 BLN LAST YEAR |
23.04 12:08 | dpa-AFX: *DANAHER Q1 NET INCOME FROM CONT. OPS. $1.088 BLN VS. $1.240 BLN LAST YEAR |
23.04 12:02 | dpa-AFX: Danaher Corp. Q1 Profit Decreases, but beats estimates |
23.04 12:02 | dpa-AFX: *DANAHER Q1 EPS FROM CONT. OPS. $1.45 VS. $1.65 LAST YEAR |
|